C. David Nicholson - Jul 1, 2022 Form 4 Insider Report for Actinium Pharmaceuticals, Inc. (ATNM)

Role
Director
Signature
/s/ David Nicholson
Stock symbol
ATNM
Transactions as of
Jul 1, 2022
Transactions value $
$0
Form type
4
Date filed
7/1/2022, 07:17 PM
Previous filing
Sep 3, 2021
Next filing
Nov 6, 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATNM Stock Option (Right to Buy) Award $0 +72.2K $0.00 72.2K Jul 1, 2022 Common Stock 72.2K $4.96 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This price represents the closing price of the Company's common stock on July 1, 2022, the date of the grant.
F2 Pursuant to the terms of the Company's 2019 Stock Plan, 2% of the options will vest each month from July 1, 2022 until fully vested.